SEC Comment Letter for AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Aug 8, 2017
AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: Aug. 8, 2017 · CIK: 0001460702 · Accession: 0000000000-17-027907
AI Filing Summary & Sentiment
Reasoning
Letter
August 7, 2017 Michael Step Chief Executive Officer Ritter Pharmaceuticals, Inc. 1880 Century Park East #1000 Los Angeles, CA 90067 Ritter Pharmaceuticals, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 26, 2017 File No. 001-37428Re: Dear Mr. Step: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance cc: Wendy Grasso
Show Raw Text
August 7, 2017 Michael Step Chief Executive Officer Ritter Pharmaceuticals, Inc. 1880 Century Park East #1000 Los Angeles, CA 90067 Ritter Pharmaceuticals, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 26, 2017 File No. 001-37428Re: Dear Mr. Step: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance cc: Wendy Grasso